Cite

HARVARD Citation

    Colomban, O. et al. (2020). Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7). JNCI cancer spectrum. 4 (3), p. . [Online]. 
  
Back to record